These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9005355)

  • 1. [A case of malignant neuroleptic syndrome. Case report].
    Martius P; Hüther R; Zilker T
    Nervenarzt; 1996 May; 67(5):418-21. PubMed ID: 9005355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroleptic malignant syndrome].
    Bryois C; Bondolfi G
    Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute delusional psychosis and neuroleptic malignant syndrome after emigration of a Russian German patient].
    Podschus J; Kirsch J; van Heys R; Winzer B
    Psychiatr Prax; 1997 May; 24(3):147-9. PubMed ID: 9273559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rhabdomyolysis in neuroleptic therapy: an abortive malignant neuroleptic syndrome?].
    Peschel O; Kurtz G; Müller-Felber W; Modell S
    Nervenarzt; 1994 Oct; 65(10):718-21. PubMed ID: 7808573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes.
    Zivković M; Mihaljević-Peles A; Sagud M; Silić A; Mihanović M
    Psychiatr Danub; 2010 Mar; 22(1):112-6. PubMed ID: 20305604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome].
    Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
    Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and catatonia. A report of three cases.
    Raja M; Altavista MC; Cavallari S; Lubich L
    Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polytrauma and malignant neuroleptic syndrome. Case presentation with diagnostic problems].
    Röther J; Jakob J; Bender HJ; Hewer W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1995 Nov; 30(7):455-7. PubMed ID: 8562725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroleptic malignant syndrome and acute life-threatening catatonia--two contrasting disease entities?].
    Heils A; Lesch KP
    Fortschr Neurol Psychiatr; 1997 Jan; 65(1):8-15. PubMed ID: 9132369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinguishing neuroleptic malignant syndrome (NMS) from NMS-like acute medical illnesses: a study of 34 cases.
    Sewell DD; Jeste DV
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):265-9. PubMed ID: 1354002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroleptic malignant syndrome].
    Dahm JB; Trenckmann U
    Med Klin (Munich); 1991 Nov; 86(11):601-4. PubMed ID: 1685215
    [No Abstract]   [Full Text] [Related]  

  • 16. Late-onset atypical psychosis: a case involving neuroleptic drug toxicity and autoimmune serological abnormalities.
    Lee K; Romero JA; Tsuang M
    Psychiatry; 1992 Aug; 55(3):297-302. PubMed ID: 1509015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome following levomepromazine discontinuation.
    Tanii H; Saka K; Inoue K; Okada M
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome and cardiac surgery. A case report.
    Sirois F
    J Cardiovasc Surg (Torino); 2008 Oct; 49(5):695-6. PubMed ID: 18670390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients.
    Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H
    Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of neuroleptic malignant syndrome via an inadvertent rechallenge in a woman with mental retardation.
    Boyd RD
    Ment Retard; 1992 Apr; 30(2):77-9. PubMed ID: 1584031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.